Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q4 2017 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2018-02-13

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q4 2017 (Next →)

Filing Date: Feb 13, 2018

Total Value: $143M (100.0% shares, 0.0% debt)

Holdings (13)

INSM Insmed Incorporated 19.2%

Value $27.44M Shares 879,910 Est. Cost $29.54 Unrealized 0.0%

ASND Ascendis Pharma A/S 14.9%

Value $21.2M Shares 529,343 Est. Cost $40.06 Unrealized —

— CymaBay Therapeutics, Inc. 14.5%

Value $20.74M Shares 2,254,502 Est. Cost $9.20 Unrealized —

— Immunomedics, Inc. 12.2%

Value $17.34M Shares 1,073,272 Est. Cost $16.16 Unrealized —

— Myokardia, Inc. 9.1%

Value $13.02M Shares 309,357 Est. Cost $42.10 Unrealized —

QURE uniQure N.V. 8.7%

Value $12.44M Shares 635,234 Est. Cost $15.23 Unrealized 0.0%

— OptiNose, Inc. 6.0%

Value $8.505M Shares 450,000 Est. Cost $18.90 Unrealized —

ACRS Aclaris Therapeutics, Inc. 4.4%

Value $6.213M Shares 251,936 Est. Cost $24.35 Unrealized 0.0%

— Biohaven Pharmaceutical Holding Company Ltd. 4.0%

Value $5.758M Shares 213,435 Est. Cost $26.98 Unrealized —

RYTM Rhythm Pharmaceuticals, Inc. 3.6%

Value $5.086M Shares 175,000 Est. Cost $26.40 Unrealized 0.0%

— Alder BioPharmaceuticals, Inc. 1.9%

Value $2.667M Shares 232,909 Est. Cost $11.45 Unrealized —

DNLI Denali Therapeutics Inc. 1.0%

Value $1.481M Shares 94,666 Est. Cost $17.97 Unrealized 0.0%

ABUS Arbutus Biopharma Corporation 0.5%

Value $760K Shares 150,592 Est. Cost $5.86 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INSM	Insmed Incorporated	879,910	$27.44M	19.2%	$29.54	0.0%	COM	457669307
ASND	Ascendis Pharma A/S	529,343	$21.2M	14.9%	$40.06	—	SPONSORED ADR	04351P101
—	CymaBay Therapeutics, Inc.	2,254,502	$20.74M	14.5%	$9.20	—	COM	23257D103
—	Immunomedics, Inc.	1,073,272	$17.34M	12.2%	$16.16	—	COM	452907108
—	Myokardia, Inc.	309,357	$13.02M	9.1%	$42.10	—	COM	62857M105
QURE	uniQure N.V.	635,234	$12.44M	8.7%	$15.23	0.0%	SHS	N90064101
—	OptiNose, Inc.	450,000	$8.505M	6.0%	$18.90	—	COM	68404V100
ACRS	Aclaris Therapeutics, Inc.	251,936	$6.213M	4.4%	$24.35	0.0%	COM	00461U105
—	Biohaven Pharmaceutical Holding Company Ltd.	213,435	$5.758M	4.0%	$26.98	—	COM	G11196105
RYTM	Rhythm Pharmaceuticals, Inc.	175,000	$5.086M	3.6%	$26.40	0.0%	COM	76243J105
—	Alder BioPharmaceuticals, Inc.	232,909	$2.667M	1.9%	$11.45	—	COM	014339105
DNLI	Denali Therapeutics Inc.	94,666	$1.481M	1.0%	$17.97	0.0%	COM	24823R105
ABUS	Arbutus Biopharma Corporation	150,592	$760K	0.5%	$5.86	0.0%	COM	03879J100